SBRT 2016

Late recurrences in stage I NSCLC

Japanese prospective study: N=180

Swedish phase II trial: N=57

Shibamoto JTO 2015

Lindberg Acta Oncol 2015

Median FU 41.5 months 3 x 15Gy @ 67%

Median FU 52.5 months 4 x 11-13 Gy @ isocenter

• Very few recurrences after 3 – 5 years  Validity of TCP modelling

Matthias Guckenberger - ESTRO SBRT Course 2016 Athens

13.06.2016

21

/